RGC
Regencell Bioscience Holdings Ltd
4.90$
-3.6%
vs. previous close
Closing price · As of: Nov 13, 2026
Statements
Cash Flow
Regencell Bioscience Holdings Ltd (RGC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Operating Cash Flow" came in at -7.7 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 349 | 434 | 411 | 410 | -0.4 | -0.7 | -0.8 | -5.3 | -5.0 | -4.0 | -3.1 | -7.7 | |
| 212 | 217 | 231 | 255 | 0.4 | 0.0 | 0.0 | 0.6 | 0.8 | 0.7 | 0.4 | 0.4 | |
| 9.4 | 8.3 | 8.8 | 9.2 | – | 0.0 | 0.0 | 2.8 | 0.9 | 0.4 | 0.2 | 3.2 | |
| – | – | – | – | 2.7 | 2.7 | 2.7 | 2.6 | – | – | – | – | |
| -43 | 36 | -67 | -35 | 0.0 | 0.1 | 0.6 | -1.0 | -0.5 | -0.6 | 0.0 | 0.4 | |
| 157 | 186 | 215 | 250 | 0.1 | 0.1 | 0.0 | 0.8 | 0.0 | 0.0 | 0.2 | 0.0 | |
| – | – | – | – | -0.1 | -0.1 | -11 | -11 | 0.1 | 5.2 | 2.7 | 2.5 | |
| 295 | 139 | 139 | 139 | – | – | – | – | – | – | – | – | |
| -147 | – | – | -229 | – | – | – | – | – | – | – | -1.8 | |
| – | – | – | – | 0.5 | 1.0 | 0.6 | -0.4 | 0.0 | 0.0 | – | – | |
| -332 | -179 | -160 | -17 | 0.5 | 1.0 | 0.4 | 22 | 0.1 | 0.1 | – | 17 | |
| -133 | 73 | 27 | -18 | 0.1 | 0.1 | -0.3 | 6.4 | -4.9 | 1.4 | -0.5 | 12 | |
| 192 | 249 | 196 | 160 | -0.4 | -0.8 | -0.8 | -6.0 | -5.0 | -4.0 | -3.3 | -7.7 |
Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.